The course of treatment for Lifnua tablets should be dynamically adjusted based on the individual patient's condition and treatment response, with symptom control as the core goal. The following provides specific explanations from three aspects: standard treatment plan, efficacy evaluation nodes, and adjustments for special populations.

1. Standard treatment plan

(1) Basic treatment course: Most patients need to take medication continuously for 12 weeks (3 months) as the initial treatment cycle to complete the basic efficacy evaluation.

(2) Extended treatment course: If symptoms are not completely controlled, it can be extended to 24 weeks (6 months), and the efficacy needs to be re evaluated every 6 weeks.

2 efficacy evaluation nodes

(1) First assessment: Symptom improvement testing should be conducted 4-6 weeks after medication to determine whether to adjust the dosage.

(2) Mid term evaluation: Confirm the degree of relief of core symptoms through imaging or biochemical indicators at 12 weeks.

3 Adjustments for Special Groups

(1) Elderly patients: It is recommended to extend the evaluation interval to 8 weeks, which may increase the total duration of treatment by 30% -50%.

(2) Patients with liver damage: The treatment rhythm should be adjusted according to the Child Pugh grading, and continuous treatment is prohibited for severe injuries.